Literature DB >> 340950

Morphologic and functional evidence for release of mast-cell products in bullous pemphigoid.

B U Wintroub, M C Mihm, E J Goetzl, N A Soter, K F Austen.   

Abstract

We studied nine patients with bullous pemphigoid, a generalized cutaneous eruption- for evidence of mast-cell involvement during development of lesions. As in other reports, six of nine patients demonstrated a serum antibody directed against the epidermal basement-membrane zone. Direct immunofluorescence studies of lesions revealed depostion of immunoglobulin and complement proteins at the basement-membrane zone in six of nine and nine of nine patients, respectively. Participation of mast cells was suggested by a sequence of pathologic alterations in which there was progressive mast-cell degranulation and late eosinophil infiltration. In addition, a factor chemotactic for human eosinophils with the size and charge characteristics of the eosinophil chemotactic factor of anaphylaxis was identified in blullous fluid. The data indicate that, in addition to activation of the complement system, involvement of mast cells is an early and continuing event in the development of the cutanenous lesions of bullous pemphigoid.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 340950     DOI: 10.1056/NEJM197802232980803

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  35 in total

1.  A major role for neutrophils in experimental bullous pemphigoid.

Authors:  Z Liu; G J Giudice; X Zhou; S J Swartz; J L Troy; J A Fairley; G O Till; L A Diaz
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

Review 2.  Bullous pemphigoid: from bench to bedside.

Authors:  Scott R A Walsh; David Hogg; P Régine Mydlarski
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Detection of elevated levels of IL-4, IL-6, and IL-10 in blister fluid of bullous pemphigoid.

Authors:  E Schmidt; B Bastian; R Dummer; H P Tony; E B Bröcker; D Zillikens
Journal:  Arch Dermatol Res       Date:  1996-06       Impact factor: 3.017

4.  Deposition of eosinophil granule proteins precedes blister formation in bullous pemphigoid. Comparison with neutrophil and mast cell granule proteins.

Authors:  L Borrego; B Maynard; E A Peterson; T George; L Iglesias; M S Peters; W Newman; G J Gleich; K M Leiferman
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

5.  Tryptase concentration in skin blister fluid from patients with bullous skin conditions.

Authors:  K Brockow; D Abeck; K Hermann; J Ring
Journal:  Arch Dermatol Res       Date:  1996-11       Impact factor: 3.017

Review 6.  Unraveling the significance of IgE autoantibodies in organ-specific autoimmunity: lessons learned from bullous pemphigoid.

Authors:  K A N Messingham; H M Holahan; J A Fairley
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

7.  Human mast cell carboxypeptidase. Purification and characterization.

Authors:  S M Goldstein; C E Kaempfer; J T Kealey; B U Wintroub
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

8.  Mouse mast cell proteases 4 and 5 mediate epidermal injury through disruption of tight junctions.

Authors:  Lora G Bankova; Cecilia Lezcano; Gunnar Pejler; Richard L Stevens; George F Murphy; K Frank Austen; Michael F Gurish
Journal:  J Immunol       Date:  2014-02-12       Impact factor: 5.422

9.  Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid.

Authors:  R Chen; G Ning; M L Zhao; M G Fleming; L A Diaz; Z Werb; Z Liu
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

10.  Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model.

Authors:  Zhi Liu; Wen Sui; Minglang Zhao; Zhuowei Li; Ning Li; Randy Thresher; George J Giudice; Janet A Fairley; Cassian Sitaru; Detlef Zillikens; Gang Ning; M Peter Marinkovich; Luis A Diaz
Journal:  J Autoimmun       Date:  2008-10-14       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.